AstraZeneca Likely To Run New Global Trial Of Covid-19 Vaccine, Says CEO after Questions over Results

Instead of adding the trial arm to an ongoing US process, a new study would be run to evaluate a lower dosage that performed better than a full amount in AstraZeneca’s studies, Pascal Soriot was quoted as saying in a Bloomberg News report.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.

x